MedPath

Alternative medications for the treatment of dually dependent on opiates and cocaine: a single-center placebo-controlled trial

Phase 1
Conditions
This study had several limitations. The most important restrictions were as follows: 1) the cross&#45
sectional nature of the study limits the overall conclusion and comprehensive forecast
and 2) using
Topiramate (TPM)&#44
Anticonvulsants/adverse effects&#44
drug therapy&#44
placebo&#44
Methadone Maintenance Treatment
Registration Number
TCTR20170201001
Lead Sponsor
non
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Terminated (Halted Prematurely)
Sex
Male
Target Recruitment
50
Inclusion Criteria

Inclusion criteria were: 1) young Male (18-55 year) patients; 2) diagnostic criteria for cocaine and opioid dependence according to DSM-IV and 3) eligible for methadone maintenance.

Exclusion Criteria

Exclusion criteria were: 1) report of positive urine test during the remedial period; 2) Hypersensitivity to TPM; 3) nephrolithiasis or renal impairment, kidney failure history, serious mental disorde

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
on a primary outcome, Topiramate was not better than placebo in reducing cocaine use 12-week generalized estimating equations (GEE) ,Topiramate was not better than placebo in reducing cocaine use 12-week generalized estimating equations (GEE)
Secondary Outcome Measures
NameTimeMethod
Secondary outcome was showed Topiramate was better than placebo in reducing cocaine craving 12-week generalized estimating equations (GEE) ,The mean [95% confidence interval (CI)] scores of cocaine craving was 11.42 (7.74â€16.10) with exp 12-week generalized estimating equations (GEE)
© Copyright 2025. All Rights Reserved by MedPath